Parametric Portfolio Associates’s Solid Biosciences SLDB Stock Holding History

Parametric Portfolio Associates’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$20K	Sell	1,100 -6,385	-85%	-$113K	﹤0.01%	3661
2021 Q4	$196K	Buy	7,485 +4,257	+132%	+$130K	﹤0.01%	3431
2021 Q3	$116K	Sell	3,228 -1,233	-28%	-$52.4K	﹤0.01%	3515
2021 Q2	$245K	Sell	4,461 -211	-5%	-$13.9K	﹤0.01%	3337
2021 Q1	$388K	Sell	4,672 -201	-4%	-$22.2K	﹤0.01%	3610
2020 Q4	$554K	Buy	4,873 +2,546	+109%	+$161K	﹤0.01%	3333
2020 Q3	$71K	Buy	2,327 +1,069	+85%	+$40.9K	﹤0.01%	3841
2020 Q2	$55K	Buy	1,258 +164	+15%	+$6.81K	﹤0.01%	3854
2020 Q1	$39K	Buy	+1,094	New	+$54.1K	﹤0.01%	3858
2019 Q4	–	Sell	-1,290	Closed	-$200K	–	3995
2019 Q3	$200K	Buy	1,290 +21	+2%	+$2.38K	﹤0.01%	3710
2019 Q2	$109K	Buy	+1,269	New	+$138K	﹤0.01%	3833

Other funds holding SLDB

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Parametric Portfolio Associates's SLDB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Solid Biosciences (SLDB) stake by 85% in Q1 2022, selling an estimated $113K and leaving 1,100 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3661.

Parametric Portfolio Associates first reported a position in SLDB in Q2 2019 and has held it in 11 quarters since. The position peaked at $554K in Q4 2020. 77 funds tracked by Wall St. Rank hold SLDB as of Q1 2022.

Parametric Portfolio Associates held 1,100 shares of Solid Biosciences worth $20K as of Q1 2022.
Parametric Portfolio Associates sold 6,385 Solid Biosciences shares in Q1 2022, an estimated $113K.
Solid Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3661 holding.
Parametric Portfolio Associates first reported a position in Solid Biosciences in Q2 2019 and has held it in 11 quarters since.
Parametric Portfolio Associates's Solid Biosciences position peaked at $554K in Q4 2020.
77 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.